Phase II Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin in Subjects With Metastatic Pancreatic Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 May 2017
At a glance
- Drugs Capecitabine (Primary) ; Gemcitabine (Primary) ; Cisplatin; Docetaxel
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 02 May 2017 Planned End Date changed from 1 Nov 2016 to 1 Nov 2017.
- 12 Apr 2016 Planned End Date changed from 1 Nov 2015 to 1 Nov 2016.
- 02 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.